Circulating levels of neurotrophic factors in autism spectrum disorders

Neuroendocrinology Letters

Volumn 35, Issue 5, 2014, Pages 380-384

  Rodrigues, David Henrique ^a,b   Rocha, Natália Pessoa ^a   Da Cunha Sousa, Larissa Fonseca ^a   Barbosa, Izabela Guimarães ^a   Kummer, Arthur ^a   Teixeira, Antônio Lucio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Autism Spectrum Disorders; BDNF; GDNF; Neurotrophic factors; Neurotrophins; NGF; NT3; NT4

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; GDNF PROTEIN, HUMAN; NGF PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NERVE CELL; NERVE CELL PLASTICITY; PROTEIN ANALYSIS; PROTEIN FUNCTION; SYNAPTOGENESIS; BLOOD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; MATERNAL AGE; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MALE; MATERNAL AGE; MIDDLE AGED; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NEURONAL PLASTICITY; NEUROTROPHIN 3; RISK FACTORS; YOUNG ADULT;

EID: 84922560639     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Abdallah MW, Mortensen EL, Greaves-Lord K, Larsen N, Bonefeld-Jørgensen EC, Nørgaard-Pedersen B et al. (2013). Neonatal levels of neurotrophic factors and risk of autism spectrum disorders. Acta Psychiatr Scand. 128(1):61-9.
2. Al-Ayadhi LY (2012). Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders. Neurochem Res. 37(2):394-400.
3. Barnea-Goraly N, Lotspeich LJ, Reiss AL (2010). Similar white matter aberrations in children with autism and their unaffected siblings: a diffusion tensor imaging study using tract-based spatial statistics. Arch Gen Psychiatry. 67(10):1052-60.
4. Cheng Y, Chou KH, Chen IY, Fan YT, Decety J, Lin CP (2010). Atypical development of white matter microstructure in adolescents with autism spectrum disorders. Neuroimage. 50(3):873-82.
5. Cherkassky VL, Kana RK, Keller TA, Just MA (2006). Functional connectivity in a baseline resting-state network in autism. Neuroreport. 17(16):1687-90.
6. Choi SW, Bhang S, Ahn JH (2011). Diurnal variation and gender differences of plasma brain-derived neurotrophic factor in healthy human subjects, Psychiatry. Res. 186(2-3):427-30.
7. Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL et al. (2003). Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised, J. Autism. Dev. Disord. 33(4):427-33.
8. Fan G, Egles C, Sun Y, Minichiello L, Renger JJ, Klein R et al (2000) Knocking the NT4 gene into the BDNF locus rescues BDNF deficient mice and reveals distinct NT4 and BDNF activities. Nat Neurosci. 3(4):350-7.
9. Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ, Sekine Y, (2006). Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry. 30(8):1529-31.
10. Katoh-Semba R, Wakako R, Komori T, Shigemi H, Miyazaki N, Ito H et al (2007). Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls. Int J Devi Neuroscience. 25:367-372.
11. Lanz TA, Bove SE, Pilsmaker CD, Mariga A, Drummond EM, Cadelina GW et al. (2012) Robust changes in expression of brainderived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma, Biomarkers 17(6):524-31.
12. Levy SE, Mandell DS, Schultz RT (2009). Autism. Lancet. 374(9701):1627-38.
13. Lu B, Pang PT, Woo NH (2005). The yin and yang of neurotrophin action. Nat Rev Neurosci. 6(8):603-14.
14. Miyazaki K, Narita N, Sakuta R, Miyahara T, Naruse H, Okado N et al (2004). Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev. 26(5):292-5.
15. Mulvihill B, Wingate M, Kirby RS, Pettygrove S, Cunniff C, Meaney FJ, et al. (2009). Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 58(10):1-20.
16. Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL et al. (2001). Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol. 49(5):597-606.
17. Neul JL (2011). Unfolding neurodevelopmental disorders: the mystery of developing connections. Nat. Med. 17(11):1353-5.
18. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, et al (2007). The epidemiology of autism spectrum disorders. Annu Rev Public Health. 28:235-58.
19. Pascual A, Hidalgo-Figueroa M, Gómez-Díaz R, López-Barneo J (2011). GDNF and protection of adult central catecholaminergic neurons. J Mol Endocrinol. 46(3):R83-92.
20. Paula CS, Fombonne E, Gadia C, Tuchman R, Rosanoff M (2011). Autism in Brazil: perspectives from science and society. Rev Assoc Med Bras. 57(1):2-5.
21. Riikonen R (2003). Neurotrophic factors in the pathogenesis of Rett syndrome. J Child Neurol. 18(10):693-7.
22. Rogers SJ, Vismara LA (2008). Evidence-based comprehensive treatments for early autism. J Clin Child Adolesc Psychol. 37(1):8-38.
23. Sajdel-Sulkowska EM, Xu M, Koibuchi N (2009). Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum. 8:366-72.
24. Sajdel-Sulkowska EM, Xu M, McGinnis W, Koibuchi N (2011). Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cerebellum. 10(1):43-8.
25. Wass S (2011). Distortions and disconnections: disrupted brain connectivity inautism. Brain Cogn. 75(1):18-28.